Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Assets (2021 - 2025)

Historic Return on Assets for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to 0.12%.

  • Arcutis Biotherapeutics' Return on Assets rose 3200.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.41% for FY2024, which is 2600.0% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Return on Assets of 0.12% as of Q3 2025, which was up 3200.0% from 0.27% recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Return on Assets peaked at 0.09% during Q1 2021, and registered a low of 0.94% during Q2 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' median Return on Assets value was 0.52% (recorded in 2021), while the average stood at 0.52%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -6100bps in 2022, then soared by 5100bps in 2024.
  • Arcutis Biotherapeutics' Return on Assets (Quarter) stood at 0.52% in 2021, then decreased by -25bps to 0.65% in 2022, then decreased by -27bps to 0.83% in 2023, then skyrocketed by 57bps to 0.36% in 2024, then skyrocketed by 66bps to 0.12% in 2025.
  • Its Return on Assets stands at 0.12% for Q3 2025, versus 0.27% for Q2 2025 and 0.37% for Q1 2025.